A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer

  • Christopher G. Willett
  • , Dan G. Duda
  • , Marek Ancukiewicz
  • , Mira Shah
  • , Brian G. Czito
  • , Rex Bentley
  • , Martin Poleski
  • , Hiroshi Fujita
  • , Gregory Y. Lauwers
  • , Madeline Carroll
  • , Douglas Tyler
  • , Christopher Mantyh
  • , Paul Shellito
  • , Daniel C. Chung
  • , Jeffrey W. Clark
  • , Rakesh K. Jain

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science